Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Recognise possible dying without false certainty, distinguish reversible deterioration, communicate the working diagnosis and repeatedly reassess comfort, goals and recovery signals.
The last days of life are usually recognised through converging physiological, symptomatic and functional changes in the context of an advanced irreversible condition. In older adults with frailty, infection, dehydration, organ decompensation and medicine effects may produce a similar appearance and sometimes improve with limited treatment. The task is therefore to make a defensible working judgement while preserving the possibility of recovery.
Gather the longitudinal story: baseline cognition and function, speed of decline, recent intake, mobility, communication, sleep, continence, recurrent admissions and response to previous treatment. Examine for comfort and remediable problems. Existing blood results or imaging may clarify advanced renal failure, infection or another driver, but routine panels and repeated observations are burdensome when they will not alter the plan.
The language used should match certainty. Explain that the person may be in the last days, what changes support this view, what could still be reversible and how the team will review. Do not give an exact time prediction that evidence cannot support. Ask how much the person wishes to know, involve important people with permission and accommodate hearing, language, cognition, cultural and spiritual needs.
Advanced cancer, heart failure, lung disease, neurological disease or dementia can reach a point where organ reserve and recovery capacity steadily fail.
Repeated minor illnesses, immobility, sarcopenia and nutritional loss may produce a stepwise trajectory in which each episode leaves a lower functional baseline.
Sepsis, aspiration, major stroke, haemorrhage or sudden organ failure may initiate the last phase, although some presentations remain partly reversible.
Reduced cardiac, respiratory, renal and metabolic reserve limits compensation, so small stressors cause disproportionate fatigue, weakness, delirium and organ dysfunction.
Diminished appetite, consciousness and neuromuscular coordination reduce eating and drinking, while dysphagia increases aspiration risk and medicine-route difficulty.
Peripheral perfusion falls, producing cool or mottled skin, while altered respiratory drive can cause irregular breathing, pauses and retained upper-airway secretions.
Organ failure, inflammation, hypoxia, dehydration and medicine accumulation contribute to fluctuating delirium, withdrawal, somnolence and eventual loss of consciousness.
Look for accelerating dependence, bedbound state, reduced transfers, weaker cough, deteriorating performance and loss of recovery after recent illnesses.
Increasing disinterest in food or drink, inability to manage tablets and coughing or fatigue with sips often accompany advanced decline.
Longer sleep, reduced speech, social withdrawal, fluctuating awareness or progressive unresponsiveness should be interpreted against baseline cognition and recent medicines.
Shallow irregular respirations, Cheyne–Stokes cycles and audible secretions may develop, but assess whether pulmonary oedema, bronchospasm or opioid toxicity needs treatment.
Cool mottled peripheries, weak pulse and falling urine output suggest reduced perfusion; exclude retention from a blocked catheter when the bladder is palpable.
More alert interaction, stronger intake, stable observations, restored mobility or response to limited treatment should trigger reconsideration of the dying diagnosis.
Infection, constipation, retention, pain, dehydration or environmental disruption can cause withdrawal and drowsiness that improve when contributors are corrected.
Opioids, benzodiazepines, anticholinergics, gabapentinoids and renally cleared medicines can mimic terminal decline through sedation, respiratory depression or myoclonus.
Hypoglycaemia, hyperglycaemia, hypercalcaemia, sodium disturbance, uraemia or adrenal insufficiency may present with weakness, confusion and reduced oral intake.
Stroke, subdural haemorrhage, seizure or non-convulsive status can abruptly alter consciousness, swallowing, speech and mobility and may require urgent intervention.
Low mood and withdrawal can reduce eating, communication and activity without the physiological pattern of imminent dying, and warrant sensitive assessment.
Pain, breathlessness, nausea, delirium and secretions may escalate rapidly unless anticipatory assessment, medicines and skilled review are available.
Dysphagia, reduced saliva and weak cough increase aspiration risk, while dry lips, coated mouth and poorly fitting dentures can cause avoidable distress.
Immobility, poor perfusion and weight loss increase pressure injury and painful stiffness, requiring proportionate repositioning, skin care and supportive surfaces.
Unexplained changes, uncertain timing and inconsistent messages can cause fear, guilt or disagreement about hydration, sedation, admission and perceived abandonment.
Once a dying label is fixed, improving signs may be overlooked, prolonging unnecessary medicine withdrawal, reduced rehabilitation or inappropriate care restrictions.
A single low intake or sleepy period is non-specific; the direction and pace of change across function, physiology and interaction are more informative.
Avoiding burdensome investigation is not neglect when the result cannot change care, but a focused test is justified when it can relieve distress.
Noisy upper-airway secretions may distress relatives more than the unconscious person; explain this while repositioning and reviewing fluid burden.
Delirium and fatigue may narrow participation, so hold important non-urgent conversations during clearer periods and support communication actively.
If the person stabilises, revisit preventive medicines, rehabilitation and nutrition rather than merely discontinuing the last-days plan.
Recognition at home must trigger practical arrangements for medication, equipment, nursing and verification after death, not documentation alone.
Diagnosing imminent dying from reduced intake without examining for infection, retention, constipation, pain or medicine toxicity.
Continuing invasive observations and routine blood tests that cannot change treatment or improve comfort.
Giving an exact prognosis while concealing substantial uncertainty from the person and family.
Stopping every medicine, including those needed for seizures, Parkinsonism or distressing symptom control.
Using opioid escalation to treat restlessness before checking pain, bladder, bowel, environment and toxicity.
Leaving relatives unprepared for altered breathing, reduced intake, drowsiness and changes in communication.
Failing to reverse care restrictions when the person becomes more alert, mobile or able to eat.
Your practice draft is saved in this browser.
An older adult with advanced frailty becomes drowsier, eats less and develops irregular breathing over several days. What is the best next step?
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes
Recognition changes the focus, not the duty of care. Stop burdensome monitoring or preventive medicines that no longer provide benefit, while continuing treatment for pain, breathlessness, anxiety, delirium, nausea, secretions, mouth discomfort and pressure risk. Review hydration separately. Establish access to anticipatory medicines, nursing support and advice across nights and weekends, especially when care continues at home or in a care home.
If signs improve, reconsider the diagnosis and restore appropriate rehabilitation, nutrition, monitoring or disease-directed treatment. A dying plan must never become an irreversible pathway. Daily multiprofessional review, explicit goals and named escalation contacts protect against both undertreatment and burdensome intervention.